Medication Fact Sheets
|
February 3, 2025

Ranolazine Explained: What to Know About This Medication

Written By
Dr. Kristin Robinson ND
Medically Reviewed by
Updated On
February 10, 2025

Chronic angina affects around 9 million Americans, causing persistent chest pain and fatigue that can make everyday tasks difficult. Ranolazine is a medication prescribed to help manage the symptoms associated with chronic angina. While it doesn’t treat the underlying cardiovascular disease, it can improve chest pain and exercise tolerance as part of a comprehensive treatment plan.

This article provides a complete guide to ranolazine, including its uses, benefits, and important safety considerations.

[signup]

What is Angina?

Angina is chest pain or discomfort that occurs when the heart doesn't receive enough oxygen-rich blood. It often feels like pressure or tightness in the chest and can be triggered by physical activity or stress. Angina is a symptom of underlying heart conditions, such as coronary artery disease, where blood vessels supplying the heart become narrowed or blocked. Angina doesn’t cause a heart attack, but it signals a higher risk for cardiovascular disease and should be managed appropriately.

There are three main types of angina:

  1. Stable Angina is the most common type, typically triggered by physical exertion or stress. It usually follows a predictable pattern and may be managed with medication and lifestyle changes.

  2. Unstable Angina is unpredictable and may occur at rest or with minimal exertion. It often lasts longer, is more intense, and requires immediate medical attention as it may signal an impending heart attack.

  3. Variant (Prinzmetal) Angina is caused by a spasm in a coronary artery that temporarily reduces blood flow to the heart. It usually happens at rest and can be severe, but it is often relieved by medication.

What is Ranolazine?

Ranolazine is primarily used to manage stable angina by helping improve exercise tolerance and reducing chest pain as part of a broader treatment approach. As an antianginal, it is classified as a sodium channel inhibitor. Unlike traditional treatments such as nitrates or beta-blockers, ranolazine alters how heart muscle cells process sodium, making the heart function more efficiently. This can reduce chest pain and improve exercise tolerance. It is commonly used alongside other cardiovascular treatments.

Development and FDA Approval

Ranolazine was approved by the FDA in 2006 after clinical trials showed it could improve exercise tolerance and reduce chest pain. Since then, it has been used as part of a comprehensive treatment plan for managing chronic angina.

How Does Ranolazine Work?

Let’s take a look at how this medication works to help manage symptoms of chronic angina.

Mechanism of Action

Ranolazine works differently from other angina medications. It affects specific channels in heart muscle cells that regulate the movement of key substances, such as sodium and calcium. These substances are essential for the heart to function properly. When too much sodium enters the heart cells, it increases calcium, causing the heart to work harder and require more oxygen. By blocking these channels, ranolazine reduces the buildup of sodium and calcium, making it easier for the heart to work and use oxygen more efficiently.

Benefits of Ranolazine

Ranolazine helps manage the symptoms of chronic angina, improving the daily lives of many patients.

Improved Exercise Tolerance

A key benefit of ranolazine is its potential to improve exercise tolerance. Angina can make movement difficult due to discomfort and fatigue. By helping the heart function more efficiently, ranolazine may allow patients to engage in physical activities with fewer interruptions from chest pain or tiredness. While it doesn’t directly affect heart rate, it reduces strain on the heart, improving the body’s ability to handle exertion.

Reduction in Chest Pain Episodes

Ranolazine reduces the frequency of chest pain episodes in individuals with chronic angina. By addressing factors that contribute to angina, such as the heart’s oxygen demand and muscle efficiency, ranolazine can help alleviate discomfort. For many individuals, fewer episodes of chest pain can significantly improve their ability to carry out everyday activities.

Dosage and Administration

Ranolazine is typically prescribed in extended-release tablets. The standard adult dosage is 500 mg twice daily, with a potential increase to 1000 mg twice daily based on individual response. Always follow the prescribed dosage and consult a healthcare provider before making any adjustments.

The dosage may need to be adjusted for individuals with kidney or liver conditions.  A healthcare provider will determine the appropriate dosage based on the individual’s health status.

Best Practices for Taking Ranolazine

​​For optimal results, follow these simple guidelines when taking ranolazine.

  • Take ranolazine with or without food. If you experience an upset stomach, take it with food.
  • Swallow the extended-release tablets whole. Do not crush or break them.
  • Do not skip doses or exceed the prescribed amount, as this can affect the medication’s effectiveness.
  • If a dose is missed, take it as soon as you remember, unless it’s nearly time for the next dose. Avoid taking two doses at once to make up for a missed dose.
  • If you have any questions or concerns, consult your doctor for further guidance.

Side Effects and Precautions

Some people may experience mild side effects, including:

  • Dizziness 
  • Headache
  • Nausea 
  • Constipation

These side effects are usually temporary and may improve as your body adjusts to the medication. If they persist or worsen, consult a healthcare provider.

Serious Adverse Effects and When to Seek Help

Seek immediate medical attention if you experience:

  • Chest pain or irregular heartbeats
  • Severe dizziness, lightheadedness, or fainting
  • Swelling in the ankles, feet, or legs
  • Unusual tiredness or weakness

Interactions with Other Medications

Certain drugs can interfere with how ranolazine is processed in the body, potentially affecting its effectiveness or increasing the risk of side effects. Grapefruit should also be avoided, as it can block the enzyme that breaks down ranolazine, leading to higher levels of the drug and a greater risk of side effects. 

Be sure to inform your healthcare provider about all medications you are taking, including over-the-counter drugs (OTC) and supplements like St. John’s wort. Your doctor will inform you about any medications that may cause interactions and adjust your treatment plan accordingly.

Insights from Medical Research

Studies suggest that ranolazine may help improve symptoms of chronic angina. The CARISA trial, a large randomized, double-blind, placebo-controlled study, indicated that ranolazine may improve exercise tolerance, delay the onset of angina, and reduce the frequency of angina attacks and the need for nitroglycerin. These findings were observed regardless of other heart medications.

Similarly, the ERICA trial suggested that ranolazine may help reduce angina symptoms and the need for nitroglycerin, even in patients already treated with amlodipine. Research is exploring its potential benefits for atrial fibrillation, though it is not FDA-approved for this use.

Ongoing Research and Future Directions

Ranolazine is included in treatment guidelines for managing chronic angina in the U.S. and Europe. Ongoing research is exploring its potential benefits for conditions such as acute coronary syndrome (ACS), microvascular coronary dysfunction (MCD), arrhythmias, and glycemic control. However, further studies are needed to fully understand its effectiveness in these areas.

Recent studies also suggest that adding ranolazine to conventional treatments may further improve exercise tolerance in patients with chronic angina. In a recent randomized, double-blind, multi-center study, patients who added ranolazine showed a 20.8-second improvement in exercise treadmill test duration compared to a placebo. These results were similar to those seen in the CARISA trial.

Both the ranolazine and placebo groups had a 34.8% incidence of adverse events, indicating that ranolazine was well-tolerated. These findings suggest ranolazine may improve exercise capacity for patients with chronic angina, although more extensive studies are needed to confirm these results.

Frequently Asked Questions

Here are answers to some common questions about ranolazine.

Can ranolazine be taken with other heart medications?

Yes, ranolazine can often be taken with other heart medications, but it is important to consult your healthcare provider first. Some medications, such as certain antiarrhythmic drugs, can interact with ranolazine and affect how it works. Your healthcare provider will review your medications to ensure no harmful interactions and adjust your treatment plan as needed.

Is it safe for long-term use?

Ranolazine is generally considered safe for long-term use in managing chronic angina. Regular check-ups with your healthcare provider are important to monitor how well the medication works and ensure it's still the proper treatment for your needs.

Can I drink alcohol while taking ranolazine?

It is recommended to limit alcohol intake while using ranolazine, as alcohol can increase the risk of side effects like dizziness or lightheadedness. Always consult your healthcare provider about alcohol use to ensure it does not interfere with your treatment.

Can ranolazine be taken if I have kidney or liver problems?

Ranolazine is processed by the liver and excreted through the kidneys. If you have liver or kidney issues, the medication may be processed more slowly, leading to higher levels in your body and an increased risk of side effects. Your healthcare provider may adjust the dosage or closely monitor you to ensure the medication remains safe and effective. Always consult your provider before making changes to your treatment plan. 

[signup]

Key Takeaways

  • Ranolazine can help manage chronic angina symptoms by reducing chest pain and improving exercise tolerance. It lowers the heart's workload, enhances oxygen use, and lessens discomfort during physical activity.
  • When used as prescribed, ranolazine may help reduce the frequency of chest pain episodes and improve overall quality of life.
  • Always consult your healthcare provider to determine whether ranolazine is the best treatment for your specific needs.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. (2024, March 11). The Hidden Aftermath of Heart Attacks: A Comprehensive Study Unveils Increased Risks. Rupa Health. https://www.rupahealth.com/post/the-hidden-aftermath-of-heart-attacks-a-comprehensive-study-unveils-increased-risks

AHA. (2025a, January 2). Heart Attack Recovery FAQs. Www.heart.org. https://www.heart.org/en/health-topics/heart-attack/life-after-a-heart-attack/heart-attack-recovery-faqs

AHA. (2025b, January 27). Coronary Microvascular Disease (MVD). Www.heart.org. https://www.heart.org/en/health-topics/heart-attack/angina-chest-pain/coronary-microvascular-disease-mvd

Anderson, S. (2022, September 21). 10 Commonly Prescribed Medications & The Nutrients They Deplete. Rupa Health. https://www.rupahealth.com/post/10-commonly-prescribed-medications-the-nutrients-they-deplete

Bryant, A. (2024a, September 3). Advil vs. Aleve vs. Tylenol: Which Pain Reliever is Best for You? Rupa Health. https://www.rupahealth.com/post/advil-vs-aleve-vs-tylenol-which-pain-reliever-is-best-for-you

Bryant, A. (2024b, November 25). Precordial Catch Syndrome: Understanding Causes & Treatment. Rupa Health. https://www.rupahealth.com/post/precordial-catch-syndrome-understanding-causes-treatment

Calcium. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/calcium

Christie, J. (2024, December 18). Coronary Calcium Scoring: What is This Important Test, What Does it Tell Us About Our Heart, and What Does it Hide? Rupa Health. https://www.rupahealth.com/post/coronary-calcium-scoring-what-is-this-important-test-what-does-it-tell-us-about-our-heart-and-what-does-it-hide

Cloyd, J. (2023a, May 1). A Functional Medicine Protocol for Coronary Artery Disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-protocol-for-coronary-artery-disease

Cloyd, J. (2023b, June 28). Complementary and Integrative Medicine Options for Patients With Liver Disease: Comprehensive Lab Testing, Nutrition, and Supplement Suggestions. Rupa Health. https://www.rupahealth.com/post/a-functional-and-integrative-medicine-approach-to-treating-liver-disease-comprehensive-testing-nutrition-and-treatment-options

Cloyd, J. (2023c, July 3). The Role of Physical Activity in Promoting Heart Health. Rupa Health. https://www.rupahealth.com/post/the-role-of-physical-activity-and-exercise-in-promoting-heart-health-including-the-use-of-alternative-exercise-modalities-such-as-tai-chi-and-qigong

Cloyd, J. (2023d, October 9). Rhythms of the Heart: Demystifying Common Types of Heart Arrhythmia. Rupa Health. https://www.rupahealth.com/post/rhythms-of-the-heart-demystifying-common-types-of-heart-arrhythmia

Cloyd, J. (2023e, November 6). How to Use St. John’s Wort Therapeutically: The Health Uses You May Never Have Heard Of. Rupa Health. https://www.rupahealth.com/post/how-to-use-st-johns-wort-therapeutically-the-health-uses-you-may-never-have-heard-of

Cloyd, J. (2024, March 7). What is Hyponatremia, and How Can You Test For It? Rupa Health. https://www.rupahealth.com/post/what-is-hyponatremia-and-how-can-you-test-for-it

Daglis, S. (2024a, February 20). Exploring the Potential of Personal Heart Monitors in Preventive Cardiovascular Care. Rupa Health. https://www.rupahealth.com/post/exploring-the-potential-of-personal-heart-monitors-in-preventive-cardiovascular-care

Daglis, S. (2024b, December 27). How Metoprolol Succinate Works: A Complete Guide. Rupa Health. https://www.rupahealth.com/post/how-metoprolol-succinate-works-a-complete-guide

DePorto, T. (2022, December 9). Worried About Heart Disease? Ask Your Provider for These 6 Specialty Labs at Your Next Appointment. Rupa Health. https://www.rupahealth.com/post/worried-about-heart-disease-ask-your-provider-for-these-6-specialty-labs-at-your-next-appointment

FDA. (2025). Drug Approval Package: Ranexa (Ranolazine) NDA #021526. Fda.gov. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021526_s000_Ranexa.cfm

Hermiz, C., & Sedhai, Y. R. (2023, June 6). Angina. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557672/

Khakham, C. (2023a, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs

Khakham, C. (2023b, August 2). Top Labs To Run Bi-Annually On Your Patients Experiencing Fatigue. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-experiencing-fatigue

Kim, K. H., & Schaller, D. J. (2023, July 31). Nitroglycerin. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482382/

Lee, J.-K., Hsieh, I-Chang., Huang, P.-H., Wu, Y.-W., Hsu, J.-C., Kuo, J.-Y., Chang, P.-Y., Wu, C.-H., & Hwang, J.-J. (2024). Ranolazine effects on exercise tolerance and angina frequency in Taiwanese stable angina: A bridging study of the CARISA randomized trial. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2024.09.018

Lee, P. M., & Gerriets, V. (2023). Nitrates. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK545149/

Magryta , C. (2024, December 12). Redefining Cardiovascular Disease: Integrating Immunity, Genetics, and Lipidology. Rupa Health. https://www.rupahealth.com/post/redefining-cardiovascular-disease-integrating-immunity-genetics-and-lipidology

Mayo Clinic. (2019). What’s the best treatment for your angina? Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/in-depth/angina-treatment/art-20046240

Mayo Clinic. (2023, May 16). Acute Coronary Syndrome - Symptoms and Causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/acute-coronary-syndrome/symptoms-causes/syc-20352136

Mayo Clinic. (2024, March 22). Angina - Symptoms and Causes. Mayo Clinic; Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/angina/symptoms-causes/syc-20369373

Mayo Clinic. (2025a). Ranolazine (oral route). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/ranolazine-oral-route/description/drg-20069114#drug-description

Mayo Clinic. (2025b). Ranolazine (oral route). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/ranolazine-oral-route/description/drg-20069114#drug-proper-use

Mayo Clinic. (2025c). Ranolazine (oral route). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/ranolazine-oral-route/description/drg-20069114#drug-precautions

MedlinePlus. (2016a). Ranolazine: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a606015.html#side-effects

MedlinePlus. (2016b). Ranolazine: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a606015.html#how

Prinzmetal Angina: Causes, Symptoms & Treatment. (2021, September 20). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/21867-prinzmetal-angina

Rayner‐Hartley, E., & Sedlak, T. (2016). Ranolazine: A Contemporary Review. Journal of the American Heart Association, 5(3). https://doi.org/10.1161/jaha.116.003196

Reed, M., Kerndt, C. C., Gopal, S., Pellegrini, M. V., & Nicolas, D. (2024a, February 28). Ranolazine. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507828/#_article-41850_s4_

Reed, M., Kerndt, C. C., Gopal, S., Pellegrini, M. V., & Nicolas, D. (2024b, February 28). Ranolazine: Mechanism of Action. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507828/#_article-41850_s3_

Reed, M., Kerndt, C. C., & Nicolas, D. (2024). Ranolazine. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507828/

Shen, L., Vavalle, J. P., Broderick, S., Shaw, L. K., & Douglas, P. S. (2016). Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease. Clinical Cardiology, 39(12), 721–727. https://doi.org/10.1002/clc.22594

Sodium. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/sodium

Stable Angina: Causes, Symptoms and Treatment. (2023, August 25). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/21847-stable-angina#overview

Sweetnich, J. (2023, June 5). Integrative Treatment Options for The Most Common Kidney Disorders: Specialty Testing, Nutrition, Supplements. Rupa Health. https://www.rupahealth.com/post/kidney-101

Unstable Angina: Causes, Symptoms and Treatment. (2021, August 19). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/21744-unstable-angina

Varanasi-Diaz, S. (2024, February 8). 10 Commonly Prescribed Medications and the Foods That Should Be Avoided with Them. Rupa Health. https://www.rupahealth.com/post/10-commonly-prescribed-medications-and-the-foods-that-should-be-avoided-with-them

Willis, L. H., Slentz, C. A., Johnson, J. L., Kelly, L. S., Craig, K. P., Hoselton, A. L., & Kraus, W. E. (2019). Effects of Exercise Training With and Without Ranolazine on Peak Oxygen Consumption, Daily Physical Activity, and Quality of Life in Patients With Chronic Stable Angina Pectoris. The American Journal of Cardiology, 124(5), 655–660. https://doi.org/10.1016/j.amjcard.2019.05.063

Yoshimura, H. (2023a, October 31). Functional Fitness: Integrative Approaches to Muscle Health and Hormonal Regulation in Men. Rupa Health. https://www.rupahealth.com/post/functional-fitness-integrative-approaches-to-muscle-health-and-hormonal-regulation-in-men

Yoshimura, H. (2023b, December 27). Epigenetics and Disease Prevention: Harnessing Lifestyle Changes in Clinical Practice. Rupa Health. https://www.rupahealth.com/post/epigenetics-and-disease-prevention-harnessing-lifestyle-changes-in-clinical-practice

Yoshimura, H. (2024, May 31). Exercise Protocols for Cardiac Rehabilitation and Heart Failure. Rupa Health. https://www.rupahealth.com/post/exercise-protocols-for-cardiac-rehabilitation-and-heart-failure

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.